Linda Avey from 23andMe appeared on CNBC's Healthy Horizons to discuss her company. The host asks Avey what she would say to critics who say the diseases arise from complex interactions of genes and environment and that what 23andMe provides is a small amount of information that could be misinterpreted. Avey replies: "We think that's poppycock. We think we should really be able to engage people directly."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.